Rare diseases
Investigational molecules
Locations
Back to Hungary556 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
HungaryStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
HungaryStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
HungaryStudy Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
HungaryStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
HungaryStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
HungaryStudy on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
HungaryStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
HungaryStudy on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination
HungaryStudy on the Long-term Safety of Vedolizumab for Children with Ulcerative Colitis or Crohn's Disease
HungaryStudy of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer
HungaryStudy on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
